Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform

DSpace/Manakin Repository

Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform

Citable link to this page

 

 
Title: Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Author: Skardal, Aleksander; Murphy, Sean V.; Devarasetty, Mahesh; Mead, Ivy; Kang, Hyun-Wook; Seol, Young-Joon; Shrike Zhang, Yu; Shin, Su-Ryon; Zhao, Liang; Aleman, Julio; Hall, Adam R.; Shupe, Thomas D.; Kleensang, Andre; Dokmeci, Mehmet R.; Jin Lee, Sang; Jackson, John D.; Yoo, James J.; Hartung, Thomas; Khademhosseini, Ali; Soker, Shay; Bishop, Colin E.; Atala, Anthony

Note: Order does not necessarily reflect citation order of authors.

Citation: Skardal, A., S. V. Murphy, M. Devarasetty, I. Mead, H. Kang, Y. Seol, Y. Shrike Zhang, et al. 2017. “Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.” Scientific Reports 7 (1): 8837. doi:10.1038/s41598-017-08879-x. http://dx.doi.org/10.1038/s41598-017-08879-x.
Full Text & Related Files:
Abstract: Many drugs have progressed through preclinical and clinical trials and have been available – for years in some cases – before being recalled by the FDA for unanticipated toxicity in humans. One reason for such poor translation from drug candidate to successful use is a lack of model systems that accurately recapitulate normal tissue function of human organs and their response to drug compounds. Moreover, tissues in the body do not exist in isolation, but reside in a highly integrated and dynamically interactive environment, in which actions in one tissue can affect other downstream tissues. Few engineered model systems, including the growing variety of organoid and organ-on-a-chip platforms, have so far reflected the interactive nature of the human body. To address this challenge, we have developed an assortment of bioengineered tissue organoids and tissue constructs that are integrated in a closed circulatory perfusion system, facilitating inter-organ responses. We describe a three-tissue organ-on-a-chip system, comprised of liver, heart, and lung, and highlight examples of inter-organ responses to drug administration. We observe drug responses that depend on inter-tissue interaction, illustrating the value of multiple tissue integration for in vitro study of both the efficacy of and side effects associated with candidate drugs.
Published Version: doi:10.1038/s41598-017-08879-x
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562747/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375225
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters